Deferasirox
NDC 67877-551, Deferasirox, tablet, for suspension, from Ascend Laboratories, LLC.
- Product NDC
- 67877-551
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210519
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-551 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFERASIROX500 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-551-30 | 67877055130 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (67877-551-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/da3295fc-5210-46a3-a5cc-7b9ec9265ecaNADAC price for package 67877055130
GET /v1/drugs/nadac/67877055130
Use it
Look up 67877-551 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-551 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-551. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.